• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Simultaneous determination of acetaminophen and oxycodone in human plasma by LC–MS/MS and its application to a pharmacokinetic study

    2018-06-20 05:50:46WeiLuShunoZhaoMengGongLuningSunLiDing
    Journal of Pharmaceutical Analysis 2018年3期

    Wei Lu,Shuno Zhao,Meng Gong,Luning Sun,Li Ding,*

    aDepartment of Pharmaceutical Analysis,China Pharmaceutical University,24 Tongjiaxiang,Nanjing 210009,PR China

    bNanjing Clinical Tech Laboratories Inc.,18 Zhilan Road,Jiangning District,Nanjing 211000,PR China

    cResearch Division of Clinical Pharmacology,the First Affiliated Hospital,Nanjing Medical University,Nanjing 210029,PR China

    1.Introduction

    Acetaminophen is a frequently used analgesic and antipyretic drug worldwide.Oxycodone hydrochloride,a semi-synthetic opiate derivative of thebaine,is widely used in analgesic agents due to remarkable analgesia effect and good tolerance[1].The FDA-approved Percocet[2],combining acetaminophen with oxycodone,can be effective in pain control and help in reducing side effects and drug dependence.The commonly used dosage regimen is 325 mg and 5 mg for acetaminophen and oxycodone,respectively.The combination of acetaminophen and oxycodone provides a synergistic and opioid-sparing effect.Additionally,this combination has a safe pharmacokinetic profile,without increasing the incidence of drug addiction and acetaminophen-associated hepatotoxicity[3–7].As the abuse of prescription opioids continues to rise,measurement of acetaminophen and oxycodone in human plasma will help researchers with better drug monitoring.

    Several methods have been developed for the determination of acetaminophen in biological matrix,including immunoassay[8],gas chromatography(GC)[9,10],capillary electrophoresis[11],high performance liquid chromatography(HPLC)with UV detector[12–16]or with tandem mass spectrometer[17–19].The analysis of oxycodone alone or with its major metabolites in human plasma with electrochemical detection[20,21],GC[22,23],liquid chromatography–tandem mass spectrometry(LC–MS)[24,25]and liquid chromatography–tandem mass spectrometry(LC–MS/MS)[26–37]has also been reported.Literature survey revealed that the majority of published methods determined acetaminophen and oxycodone in biological fluids individually,or in combination with other drugs[38–42].Devarakonda et al.[43]quantified acetaminophen and oxycodone in plasma with liquid-liquid extraction,but the sample preparation and method validation were not clearly described.

    Simultaneous determination of acetaminophen and oxycodone in human plasma by LC–MS/MS is challenged by two problems,one is the weak retention of the analytes on traditional C18columns,and the other is that the plasma concentration of acetaminophen is much higher than that of oxycodone.The present article focuses on troubleshooting in method development,including screening of columns for better retention of the analytes,and overcoming the MS response saturation to acetaminophen while ensuring the detection sensitivity for oxycodone.Finally,the application of the validated method to a clinical pharmacokinetic study in healthy Chinese volunteers following oral administration of Percocet tablet is described.

    2.Experimental

    2.1.Chemicals and reagents

    The reference standards of acetaminophen and acetaminophen-d4 were purchased from Toronto Research Chemicals(Toronto,Canada).The reference standards of oxycodone hydrochloride and oxycodone-d3 solution were purchased from Sigma-Aldrich Company,USA.HPLC grade methanol and acetonitrile were purchased from Merck KGaA(Darmstadt,Germany).Acetic acid and ammonium acetate were obtained from Sigma-Aldrich Company,USA.Ultrapure water was generated in house with a Milli-Q system(Millipore,Bedford,MA,USA)and was used throughout the study.Blank human plasma was obtained from healthy Chinese volunteers.All the volunteers were given informed consent.

    2.2.Liquid chromatography and mass spectrometric conditions

    An Exion LC system(Applied Biosystems/Sciex,USA)consisted of a binary AD pump,a vacuum degasser,an autosampler(AD multiplate sampler)and a temperature-controlled compartment for column(AD column oven).Separation of analytes was performed on a Venusil ASB C18column(2.1 mm × 50 mm,3 μm,150 A;Bonna-Agela Technologies,Tianjin,China)with a Security Guard Cartridges C18(4 mm×2.0 mm,Phenomenex,Torrance,CA,USA)maintained at 40°C.The autosampler temperature was set at 8°C.The mobile phase was composed of 2 mM ammonium acetate containing 0.1%(v/v)acetic acid(A;pH 3.6)and acetonitrile(B).The gradient elution program started at a composition of 6%B for 0.4 min,and then was ramped to 15%B at 0.5 min and held for another 1.5 min.The composition of mobile phase B was maintained at 80%from 2.1min to 2.8 min.The system returned to the initial condition at 3.0 min and held for another 1.5 min.The total run time was 4.5 min and the flow rate was constantly 0.5 mL/min.The injection volume was 5μL.

    Detection of analytes and internal standards was operated on a triple quadrupole mass spectrometer,AB SCIEX Triple Quad?6500+(Applied Biosystems/Sciex,USA),equipped with an electrospray ion source in positive mode.Quantitation was performed using the multiple reaction monitoring(MRM)with a dwell time of 100 ms per transition.The MRM parameters of acetaminophen,oxycodone,acetaminophen-d4 and oxycodone-d3 are listed in Table 1.The optimized source parameters were as follows∶30 psi for curtain gas;8 psi for collision activation dissociation;650°C for turbo heater temperature;3500 V for ionspray voltage;50 psi for Gas 1;55 psi for Gas 2.Quadrupole 1 and quadrupole 3 weremaintained at unit resolution.Data processing was performed using Analyst 1.6.3 software.The fragmentation of acetaminophen(A),oxycodone(B),acetaminophen-d4(C)and oxycodone-d3(D)is given in Fig.1.

    Table 1 MRM parameters of acetaminophen,oxycodone,acetaminophen-d4 and oxycodone-d3.

    2.3.Preparation of stock and working solutions

    Primary stock solutions for preparation of calibration standards and quality control(QC)samples were prepared from separate weighing.The standard stock solutions of acetaminophen,oxycodone and acetaminophen-d4 were prepared by dissolving accurately weighed compounds in acetontrile-water(50∶50,v/v)to give a concentration of 1.0 mg/mL.The primary standard solution of oxycodone-d3 in methanol was provided at a certified concentration of 1.0 mg/mL.The combined working solutions of analytes over the desired concentration range were prepared by further dilution of stock solutions with acetontrile-water(50∶50,v/v).A combined internal standard working solution was prepared in acetontrile-water(50∶50,v/v)at 10.0 ng/mL for oxycodone-d3 and 80.0ng/mL for acetaminophen-d4.All stock and working solutions were stored at-20°C and brought to room temperature before use.

    2.4.Preparation of calibration standards and QC samples

    The calibration standards and QC samples were prepared by spiking plasma with appropriate volume of respective working solutions.Calibration standards were prepared at concentrations of 40.0,80.0,200,600,2000,5000,and 8000 ng/mL for acetaminophen;0.200,0.400,1.00,3.00,10.0,25.0,and 40.0 ng/mL for oxycodone.QC samples were prepared at 40.0ng/mL(lower limitofquantification,LLOQ),100ng/mL (low QC,LQC),1200 ng/mL(middle quality control,MQC),and 6400 ng/mL(high quality control,HQC)for acetaminophen;0.200ng/mL(LLOQ),0.500 ng/mL(LQC),6.00ng/mL(MQC),and 32.0 ng/mL(HQC)for oxycodone.

    2.5.Sample preparation

    50μL aliquot of plasma sample was transferred to a clean 96-well plate and mixed with 25μL of internal standard working solution.The mixture was deproteinized with 200μL acetonitrile,vortex-mixed for 10min,and then centrifuged at 4000 rpm for 10 min.30μL of the supernatant was transferred to another clean 96-well plate,to which 330μL of acetontrile-water(10∶90,v/v)was added.After vortex mix for 3min,the mixture was injected into the LC-MS/MS system for analysis.

    2.6.Method validation

    The validation of this method was carried out following the USFDA guidelines[44].The validation included specificity,linearity,precision and accuracy,recovery,matrix effect,dilution integrity,carryover effect and stability.

    Fig.1.Product ion mass spectra of(A)acetaminophen,(B)oxycodone,(C)acetaminophen-d4 and(D)oxycodone-d3 in positive mode and their proposed fragmentation patterns.

    The specificity was tested for interference in the MRM channels using the proposed extraction procedure and LC–MS/MS conditions.Six batches of blank plasma obtained from six individual volunteers were analyzed and the results were compared to those obtained from samples at LLOQ.Best-fit calibration curves of peak area ratio versus analyte concentrations were drawn for acetaminophen and oxycodone.The calibration curve was fitted to a 1/x2weighed regression analysis where x is the concentration of the analyte.Precision and accuracy were evaluated at four concentration levels(LLOQ,LQC,MQC,and HQC)in six replicates.Intra-run precision and accuracy were assessments of precision and accuracy during a single analytical run.Inter-run precision and accuracy were evaluated over two days by quantification of three validation runs.Recovery experiments were performed by comparing peak area of extracted samples(spiked before extraction)to the peak area of unextracted samples(QC working solutions spiked in extracted plasma)at LQC,MQC and HQC levels.The matrix effect was assessed by comparing the peak area obtained from an amount of the analyte added in extracted blank plasma to the peak area obtained from equal concentration of the analyte in solvent.Dilution integrity was performed with six replicates each for samples spiked at concentrations of HQC and 2 times of the upper limit of quantification(ULOQ)diluted 5-fold with blank plasma.In this study,stability tests evaluated the stability of acetaminophen and oxycodone in stock solutions and plasma samples under different conditions.For stock solutions,the stability was evaluated by comparing the area response of analytes in stability samples to that of freshly prepared stock solutions.For plasma samples,bench top stability,autosampler stability,freezethaw stability and long-term stability were evaluated with three replicates each at LQC and HQC levels.

    2.7.Pharmacokinetic study

    Ten healthy Chinese volunteers were enrolled in the clinical pharmacokinetic study.Preliminary screening involved a medical history,physical examination,medical and laboratory evaluations.The protocol approval was obtained from a local ethics committee and informed consent was obtained from each subject.After an overnight fast of at least 10h,all subjects were administered with a single dose of one Percocet tablet(acetaminophen/oxycodone,325mg/5mg,Endo Pharmaceuticals Inc.).Blood samples were collected before drug administration(0h)and at 0.17,0.33,0.5,0.75,1,1.33,1.67,2,2.5,3,4,5,6,8,10,12 and 24h post-dosing.Whole blood was collected into heparinized tubes and centrifuged at 3000rpm for 5min.The plasma samples were stored at-20°C until analysis.The pharmacokinetic parameters were calculated with noncompartment model using WinNonlin software version 6.4.

    3.Results and discussion

    3.1.Method development

    Fig.2.The MS response to acetaminophen obtained by using different volumes of acetontrile-water(10∶90,v/v)to dilute the supernatant of deproteinized samples.

    The method development included selection of mobile phase,column types,MS detector,MS parameters and sample extraction.Acetaminophen and oxycodone are compounds with low lipophilicity and retain weakly on C18columns;thus the initial organic phase ratio should be low to achieve appropriate chromatographic separation.In the column screening stage,appropriate retention for both acetaminophen and oxycodone could not achieve on numerous C18columns,such as a Zorbax Eclipse Plus C18column(2.1mm × 50 mm,3.5 μm;Agilent Technologies),a Zorbax Extend-C18column(2.1 mm × 50 mm,3.5 μm;Agilent Technologies)and a Poroshell 120 SB-C18column(2.1 mm × 50 mm,2.7 μm;Agilent Technologies),except on an Ultimate XB-C18column(2.1mm × 100 mm,3 μm;Welch Materials,Inc.,Shanghai,China).It was observed that pure water and acetonitrile as mobile phase gave the best sensitivity and peak shape on the Ultimate XB-C18column.Tailing peak was observed when methanol was used as mobile phase B.Addition of acid in mobile phase A resulted in oxycodone eluted at dead time and addition of ammonium acetate led to unacceptable peak shapes of oxycodone.However,endogenous interference and matrix effect existed while pure water was employed as mobile phase A.A Venusil ASB C18column(2.1 mm × 50 mm,3 μm,150 ?)was then tested.The optimized mobile phase was composed of 2 mM ammonium acetate containing 0.1%(v/v)acetic acid and acetonitrile to achieve symmetrical peak shapes and better MS response.Higher concentration of ammonium acetate at 5 mM and 10 mM would inhibit MS response for all analytes.More addition of acid like 0.2%(v/v)acetic acid or 0.1%(v/v)formic acid in aqueous mobile phase would weaken the chromatographic retention of the analytes.The difference between the above two columns lies in that the Ultimate XB-C18column is a traditional reversed-phase column with endcapping while the Venusil ASB C18column is an uncapped hydrophilic column.The end-capping process might increase the lipophilicity of stationary phase,resulting in weak absorption of polar compounds.The hydrophilic column could provide better chromatographic retention and separation for strong polar compounds within a pH range of 1–5.The proportion of organic phase started at 6%to elute endogenous substance,and then increased to 15%to separate acetaminophen and oxycodone.Optimized flow rate of 0.5 mL/min helped in separation and elution of all compounds in 2 min.Whereafter,the composition of mobile phase B was set at 80%for 0.8 min to wash column and inhibit matrix effect.The elution program changed to the initial condition in order to back toward equilibrium state.

    The MS-MS detection was initially performed on an API 4000 mass spectrometer(Applied Biosystems/Sciex,USA).The plasma concentration of acetaminophen was much higher than that of oxycodone after oral administration of Percocet tablet.If the analytes in plasma were not diluted,the plasma concentration of acetaminophen would be so high that the saturation of MS response to acetaminophen would result in its poor linearity of calibration curve.This means that the analytes in plasma should be diluted for determination of acetaminophen.However,if the plasma sample was massively diluted,the quantification of oxycodone at LLOQ was difficult to ensure.Even though the much higher sensitive instrument AB SCIEX Triple Quad?6500+was applied,the problems were not easily overcome without further optimization described below.

    By using an AB SCIEX Triple Quad?6500+mass spectrometer,the protonated molecular ion[M+H]+was chosen as the parent ion in the Q1 full scan spectra for acetaminophen,oxycodone and the internal standards.The parent ion was used as the precursor ion to obtain the product ion in the Q3 spectra.The fragment ions with the highest relative abundance were atm/z110.1,298.1,114.1,and 301.1 for acetaminophen,oxycodone,acetaminophen-d4 and oxycodone-d3,respectively(Fig.1).Interestingly,MRM transitions atm/z316.1→241.1 for oxycodone andm/z319.0→244.1 for oxycodone-d3 showed more steady and reproducible signal intensities.Gaudette et al.[35]reported the fragmentation pattern of these transitions.The authors speculated that transitions atm/z316.1→298.1 for oxycodone andm/z319.0→301.1 for oxycodone-d3 might be the results of dehydration rearrangements.The mass-to-charge ratios of[M+H-H2O]+ions for oxycodone and oxycodone-d3 corresponded to 298.1 and 301.1.Ion source parameters and electrical parameters were optimized by monitoring the selected mass transition for the analytes.The great difference in the concentration ranges between acetaminophen and oxycodone made it challenging that both analytes in processed samples could give suitable signal intensities simultaneously via the same sample preparation.In order to avoid the MS response saturation to acetaminophen as well as guarantee the LLOQ of oxycoden detection,the analytes in plasma were diluted to a limited extent.Despite massive dilution of analytes in plasma,the MS response saturation to acetaminophen could not be avoided completely.Optimization of collision energy was also conducted to make fewer product ions of acetaminophen generated in Q3 to avoid the MS response saturation to acetaminophen.The MS condition optimization test showed that to obtain the highest intensity for acetaminophen,the collision energy of 20V should be adapted.Actually,a collision energy we wanted should inhibit the MS response saturation to acetaminophen.This meant that the collision energy should be increased appropriately to decrease the generation of the product ions of acetaminophen to an acceptable extent.Finally,the collision energy for acetaminophen was adjusted to 42V to obtain adaptive MS response.Other optimized parameters are listed in Table 1.

    Previous pharmacokinetic research of drug formulations combining acetaminophen and oxycodone reported extraction of acetaminophen and oxycodone simultaneously from human plasma with liquid-liquid extraction[43].As the purpose was to develop a simple and rapid method,protein precipitation was tested.Precipitants including methanol,acetonitrile and methanol-acetontrile(1∶1,v/v)were compared.Single precipitant of acetonitrile showed higher extraction recovery and negligible matrix effect.Due to the saturation of MS response to acetaminophen at high concentration level,the volume of acetontrilewater(10∶90,v/v)used to dilute the supernatant of deproteinized samples was tested.The results of a 4-fold dilution,an 8-fold dilution and a 12-fold dilution are given in Fig.2.A 12-fold dilution,30μL of the supernatant diluted with 330μL of acetontrile-water(10∶90,v/v),showed the best linearity.The major advantage was its efficiency in simultaneous extraction of both analytes and internal standards with single step of protein precipitation.

    3.2.Method validation

    3.2.1.Specificity

    The typical chromatograms of blank plasma,drug-free plasma spiked with both analytes at LLOQ and a clinical sample from a volunteer at 4 h after single oral administration of one Percocet tablet are shown in Fig.3.No significant endogenous interference was observed in blank plasma at the retention time of acetaminophen,oxycodone and internal standards.Potential interference of stable isotope-labeling internal standards was also evaluated in this study.The internal standards had no interference in the channel of acetaminophen and oxycodone.

    3.2.2.Linearity

    Table 2 Intra-run and inter-run precision and accuracy data for acetaminophen and oxycodone in human plasma.

    The calibration curves showed good linearity over the concentration of 40.0–8000 ng/mL for acetaminophen and 0.200–40.0ng/mL for oxycodone.The correlation coefficient(r)of the weighed calibration curves for both analytes during the validation was≥0.995.Precision and accuracy of the back-calculated concentrations of calibration standards well met the acceptance criteria.

    3.2.3.Precision and accuracy

    The intra-run and inter-run precision and accuracy was summarized in Table 2.The regression equations for calibration curves were used to back-calculate the measured values of QC samples at four concentration levels.For both acetaminophen and oxycodone,the deviations of mean value from the nominal value were all within±15%and the coefficient of variation(CV)determined at each concentration level did not exceed 10.1%.

    3.2.4.Recovery

    Six replicates at LQC,MQC and HQC were prepared for recovery experiment.The recovery extent of each analyte and its corresponding internal standard was consistent and reproducible.The mean recovery data(with the precision)at LQC,MQC and HQC was 96.0%(7.6%),94.7%(5.0%),and 95.7%(4.5%)for acetaminophen;91.1%(5.4%),94.0%(2.4%),and 94.7%(2.3%)for oxycodone.The recovery of acetaminophen-d4 was 95.3%with the precision of 9.3%.The recovery of oxycodone-d3 was 94.1%with the precision of 2.6%.

    3.2.5.Matrix effect

    No significant matrix effect was observed in six batches of human plasma for both analytes at three concentration levels(low,middle and high).The matrix effects at concentrations of LQC,MQC and HQC were(96.7±6.0)%,(97.8±3.2)%,and(98.5±1.4)%for acetaminophen;(96.6±2.7)%,(98.6±1.1)%,and(97.3±1.0)%for oxycodone.The matrix effect of acetaminophen-d4 and oxycodone-d3 was(92.4±1.6)%and(98.7±1.6)%,respectively.

    3.2.6.Dilution integrity

    The diluted samples were prepared by a 5-fold dilution of samples at HQC and 2 times of the ULOQ with blank plasma.The determined concentrations were corrected for dilution factor.The mean back calculated concentrations for both analytes at each level were within 85%–115%of their nominal values.The maximum of CV was 6.8%.The results demonstrated that the ULOQ could be extended to 16,000 ng/mL for acetaminophen and 80.0 ng/mL for oxycodone by a 5-fold dilution with blank plasma.

    3.2.7.Carryover effect

    Carryover was assessed and monitored by analyzing blank plasma samples instantly following plasma samples at ULOQ.No obvious response at the retention time of analytes was observed in blank matrix samples.

    3.2.8.Stability

    The stock solution was found to be stable for 20 h at room temperature and 33 days at-20°C.Table 3 lists the stability ofacetaminophen and oxycodone in human plasma under different conditions.Bench top stability experiment was conducted to keep QC samples at room temperature for 24h.The freeze-thaw stability was determined over three freeze-thaw cycles.The processed samples were analyzed after being kept in autosampler at 8°C for 24h(autosampler stability).The storage time for evaluating longterm stability at-20°C was designed to be 23 days.

    Table 3 Stability of acetaminophen and oxycodone in human plasma under different storage conditions.

    Fig.4.Mean plasma concentration-time pro files of(A)acetaminophen and(B)oxycodone in human plasma.

    3.3.Method application

    The validated method was applied to quantify acetaminophen and oxycodone in human plasma samples collected from healthy Chinese volunteers after a single oral administration of one Percocet tablet.The mean plasma concentration-time pro file of acetaminophen and oxycodone is shown in Fig.4.The typical pharmacokinetic parameters are presented in Table 4.No literature revealed the pharmacokinetic pro file of acetaminophen after administration of Percocet.Gammaitoni et al.[30]only evaluated the pharmacokinetics of oxycodone following single-dose administration of Percocet at three dose levels.For the 325mg/5mg(acetaminophen/oxycodone)dose level,the reported mean values of peak plasma concentration(Cmax),area under the plasma concentration-time curve from 0h to 24h(AUC0–24),time to peak plasma concentration(Tmax)and terminal elimination half-life(t1/2)were 9.96ng/mL,48.62hng/mL,1.33h and 3.28h,respectively.AUC0–24andt1/2of oxycodone listed in Table 4 were consistent with those earlier reported values.Cmaxof oxycodone in Table 4 was slightly higher than the value in the previous study whileTmaxwas somewhat lower.This may be due to differences in race,age and genetics of the study subjects.

    Table 4 Pharmacokinetic parameters of acetaminophen and oxycodone in healthy Chinese volunteers following oral administration of one Percocet tablet(mean±SD,n=10).

    4.Conclusion

    A simple method has been developed and validated for determination of acetaminophen and oxycodone in human plasma.To the best of our knowledge,no published methods are available for simultaneous quantification of acetaminophen and oxycodone in human plasma using protein precipitation so far.The validated method has advantages in terms of the usage of simple protein precipitation extraction and a short analysis time,which promotes high-throughput pharmacokinetic study and is useful for routine therapeutic drug monitoring.This method has been successfully applied to a pharmacokinetic study in healthy Chinese volunteers following oral administration of one Percocet tablet.

    Conflicts of interest

    The authors declare that there are no conflicts of interest.

    [1]H.Ma,Y.Liu,L.Huang,et al.,The adverse events of oxycodone in cancerrelated pain∶a systematic review and meta-analysis of randomized controlled trials,Medicine 95(2016)∶e3341.

    [2]L.R.Webster,B.Bath,R.A.Medve,Opioid formulations in development designed to curtail abuse∶who is the target?Expert Opin.Investig.Drugs 18(2009)255–263.

    [3]S.Natoli,M.Lazzari,R.Carpenedo,et al.,Retrospective evaluation of a fixeddose combination of oxycodone and acetaminophen to manage moderate pain∶the lower the better,Adv.Ther.33(2016)1025–1032.

    [4]B.Ward,J.M.Alexander-Williams,Paracetamol revisited∶a review of the pharmacokinetics and pharmacodynamics,Acute Pain.2(1999)139–149.

    [5]S.A.Cooper,H.Precheur,D.Rauch,et al.,Evaluation of oxycodone and acetaminophen in treatment of postoperative dental pain,Oral.Surg.Oral.Med.Oral.Pathol.50(1980)496–501.

    [6]J.A.Forrest,J.A.Clements,L.F.Prescott,Clinical pharmacokinetics of paracetamol,Clin.Pharmacokinet.7(1982)93–107.

    [7]N.Huang,J.Zeng,J.Liang,et al.,A randomized,double-blind,placebo-controlled study of oral oxycodone plus acetaminophen for the treatment of pain in photodynamic therapy on port wine stains,Photodiagnosis Photodyn.Ther.11(2014)134–140.

    [8]S.E.Halcomb,M.L.Sivilotti,A.Goklaney,et al.,Pharmacokinetic effects of diphenhydramine or oxycodone in simulated acetaminophen overdose,Acad.Emerg.Med.12(2005)169–172.

    [9]A.Trettin,A.A.Zoerner,A.Bohmer,et al.,Quantification of acetaminophen(paracetamol)in human plasma and urine by stable isotope-dilution GC-MS and GC-MS/MS as penta fluorobenzyl ether derivative,J.Chromatogr.B Analyt.Technol.Biomed.Life Sci.879(2011)2274–2280.

    [10]M.D.Rawlins,D.B.Henderson,A.R.Hijab,Pharmacokinetics of paracetamol(acetaminophen)after intravenous and oral administration,Eur.J.Clin.Pharmacol.11(1977)283–286.

    [11]M.E.Bosch,A.J.R.Sanchez,F.S.Rojas,et al.,Determination of paracetamol∶historical evolution,J.Pharm.Biomed.Anal.42(2006)291–321.

    [12]K.Allegaert,M.Y.Peeters,B.Beleyn,et al.,Paracetamol pharmacokinetics and metabolism in young women,BMC Anesthesiol.15(2015)∶163.

    [13]K.Allegaert,B.J.Anderson,G.Naulaers,et al.,Intravenous paracetamol(propacetamol)pharmacokinetics in term and preterm neonates,Eur.J.Clin.Pharmacol.60(2004)191–197.

    [14]O.Y.P.Hu,L.H.Pao,S.T.Ho,et al.,Pharmacokinetic properties and relative bioavailability of acetaminophen tablets,J.Med.Sci.11(1991)281–295.

    [15]A.M.Rittau,A.J.McLachlan,Investigating paracetamol pharmacokinetics using venous and capillary blood and saliva sampling,J.Pharm.Pharmacol.64(2012)705–711.

    [16]R.A.Langford,M.Hogg,A.R.Bjorksten,et al.,Comparative plasma and cerebrospinal fluid pharmacokinetics of paracetamol after intravenous and oral administration,Anesth.Analg.123(2016)610–615.

    [17]J.Cha,B.K.Kim,M.R.Gwon,et al.,Development and validation of a UPLC-MS/MS method for the quantification of acetaminophen in human plasma and its application to pharmacokinetic studies,Transl.Clin.Pharmacol.24(2016)30–36.

    [18]S.F.Cook,J.K.Roberts,S.Samiee-Zafarghandy,et al.,Population pharmacokinetics of intravenous paracetamol(acetaminophen)in preterm and term neonates∶model development and external evaluation,Clin.Pharmacokinet.55(2016)107–119.

    [19]S.F.Cook,A.D.King,J.N.van den Anker,et al.,Simultaneous quantification of acetaminophen and five acetaminophen metabolites in human plasma and urine by high-performance liquid chromatography-electrospray ionizationtandem mass spectrometry∶method validation and application to a neonatal pharmacokinetic study,J.Chromatogr.B Analyt.Technol.Biomed.Life Sci.1007(2015)30–42.

    [20]J.J.Schneider,E.J.Triggs,D.W.A.Bourne,et al.,Determination of oxycodone in human plasma by high-performance liquid chromatography with electrochemical detection,J.Chromatogr.B Biomed.Sci.Appl.308(1984)359–362.

    [21]K.P.Leow,M.T.Smith,J.A.Watt,et al.,Comparative oxycodone pharmacokinetics in humans after intravenous,oral,and rectal administration,Ther.Drug Monit.14(1992)479–484.

    [22]P.V?litalo,M.Kokki,V.P.Ranta,et al.,Maturation of oxycodone pharmacokinetics in neonates and infants∶a population pharmacokinetic model of three clinical trials,Pharm.Res.34(2017)1125–1133.

    [23]B.Parodi,E.Russo,G.Caviglioli,et al.,Buccoadhesive oxycodone hydrochloride disks∶plasma pharmacokinetics in healthy volunteers and clinical study,Eur.J.Pharm.Biopharm.44(1997)137–142.

    [24]M.Kokki,M.Heikkinen,P.V?litalo,et al.,Maturation of oxycodone pharmacokinetics in neonates and infants∶oxycodone and its metabolites in plasma and urine,Br.J.Clin.Pharmacol.83(2017)791–800.

    [25]B.Lalovic,E.Kharasch,C.Hoffer,et al.,Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects∶role of circulating active metabolites,Clin.Pharmacol.Ther.79(2006)461–479.

    [26]G.T.Hao,H.Y.Zhou,H.Z.Gao,et al.,Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain,Pharmacol.Rep.66(2014)153–158.

    [27]T.I.Saari,H.Ihmsen,P.J.Neuvonen,et al.,Oxycodone clearance is markedly reduced with advancing age∶a population pharmacokinetic study,Br.J.Anaesth.108(2012)491–498.

    [28]M.Neuvonen,P.J.Neuvonen,Determination of oxycodone,noroxycodone,oxymorphone,and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry,Ther.Drug Monit.30(2008)333–340.

    [29]W.B.Fang,M.R.Lofwall,S.L.Walsh,et al.,Determination of oxycodone,noroxycodone and oxymorphone by high-performance liquid chromatography–electrospray ionization-tandem mass spectrometry in human matrices∶in vivo and in vitro applications,J.Anal.Toxicol.37(2013)337–344.

    [30]A.R.Gammaitoni,M.W.Davis,Comparison of the pharmacokinetics of oxycodone administered in three Percocet formulations,J.Clin.Pharmacol.42(2002)192–197.

    [31]J.Hardy,R.Norris,H.Anderson,et al.,Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?Support.Care Cancer 20(2012)767–772.

    [32]J.Malone,L.Hughes,An HPLC-MS/MS method for the determination of oxycodone,noroxycodone&oxymorphone in human plasma,Almac Sciences(2014),http∶//dx.doi.org/10.13140/RG.2.1.5059.0242.

    [33]M.Dawson,B.Fryirs,T.Kelly,et al.,A rapid and sensitive high-performance liquid chromatography-electrospray ionization-triple quadrupole mass spectrometry method for the quantitation of oxycodone in human plasma,J.Chromatogr.Sci.40(2002)40–44.

    [34]A.E.Olesen,R.Upton,D.J.R.Foster,et al.,A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesia,Clin.Pharmacokinet.49(2010)817–827.

    [35]F.Gaudette,A.Sirhan-Daneau,M.St-Onge,et al.,Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatographytandem mass spectrometry,J.Chromatogr.B 1008(2016)174–180.

    [36]M.Wagner,E.Bourgogne,E.Varesio,et al.,Quantitation of polar analytes using column-switching∶application to oxycodone and three metabolites in human plasma,J.Chromatogr.B 878(2010)637–644.

    [37]F.Pantano,S.Brauneis,A.Forneris,et al.,Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine∶application to real cases,Clin.Chem.Lab.Med.(2017),http∶//dx.doi.org/10.1515/cclm-2016-0990.

    [38]T.Dahn,J.Gunn,S.Kriger,et al.,Quantitation of morphine,codeine,hydrocodone,hydromorphone,oxycodone,oxymorphone,and 6-monoacetylmorphine(6-MAM)in urine,blood,serum,or plasma using liquid chromatography with tandem mass spectrometry detection,Methods Mol.Biol.603(2010)411–422.

    [39]X.Qiu,D.Lou,D.Su,et al.,Simultaneous determination of acetaminophen and dihydrocodeine in human plasma by UPLC-MS/MS∶its pharmacokinetic application,J.Chromatogr.B 992(2015)91–95.

    [40]R.Coles,M.M.Kushnir,G.J.Nelson,et al.,Simultaneous determination of codeine,morphine,hydrocodone,hydromorphone,oxycodone,and 6-acetylmorphine in urine,serum,plasma,whole blood,and meconium by LC-MSMS,J.Anal.Toxicol.31(2007)1–14.

    [41]H.C.Atkinson,I.Stanescu,C.Frampton,et al.,Pharmacokinetics and bioavailability of a fixed-dose combination of ibuprofen and paracetamol after intravenous and oral administration,Clin.Drug Investig.35(2015)625–632.

    [42]T.Zhu,L.Ding,X.Guo,et al.,Simultaneous determination of tramadol and acetaminophen in human plasma by LC–ESI–MS,Chromatographia 66(2007)171–178.

    [43]K.Devarakonda,T.Morton,R.Margulis,et al.,Pharmacokinetics and bioavailability of oxycodone and acetaminophen following single-dose administration of MNK-795,a dual-layer biphasic IR/ER combination formulation,under fed and fasted conditions,Drug Des.Dev.Ther.8(2014)1125–1134.

    [44]Guidance for Industry,Bioanalytical Method Validation,U.S.Department of Health and Human Services,Food and Drug Administration Centre for Drug Evaluation and Research(CDER),Centre for Veterinary Medicine(CVM),May,2001.

    久久午夜亚洲精品久久| 国产高清视频在线播放一区| 老女人水多毛片| 久久天躁狠狠躁夜夜2o2o| 99久久久亚洲精品蜜臀av| 国产成人欧美在线观看| a级毛片a级免费在线| 亚洲精品一区av在线观看| 激情在线观看视频在线高清| 久久国产精品人妻蜜桃| 久久草成人影院| 久久亚洲真实| 天堂√8在线中文| 男人舔奶头视频| 欧美中文日本在线观看视频| 亚洲aⅴ乱码一区二区在线播放| 精品一区二区免费观看| 9191精品国产免费久久| 国产精品野战在线观看| 高清在线国产一区| 亚洲av不卡在线观看| 国产v大片淫在线免费观看| 国产黄色小视频在线观看| 草草在线视频免费看| 免费在线观看影片大全网站| 少妇熟女aⅴ在线视频| 国产探花在线观看一区二区| 国产精品嫩草影院av在线观看 | 国产亚洲欧美98| 欧美高清性xxxxhd video| 女生性感内裤真人,穿戴方法视频| 我的女老师完整版在线观看| 国产男靠女视频免费网站| 国产午夜精品论理片| 午夜久久久久精精品| 老司机午夜福利在线观看视频| 亚洲国产色片| 91久久精品国产一区二区成人| 亚洲无线在线观看| 色吧在线观看| 国产极品精品免费视频能看的| 精品一区二区三区av网在线观看| 日本撒尿小便嘘嘘汇集6| 欧美xxxx黑人xx丫x性爽| 欧美一区二区国产精品久久精品| 久久99热这里只有精品18| 无遮挡黄片免费观看| 国产一区二区三区视频了| 久久国产精品影院| 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | 久久午夜福利片| 久久6这里有精品| 亚洲精品色激情综合| 亚洲成人精品中文字幕电影| 成人高潮视频无遮挡免费网站| 高清在线国产一区| 国产精品美女特级片免费视频播放器| 淫秽高清视频在线观看| eeuss影院久久| 久久精品夜夜夜夜夜久久蜜豆| 村上凉子中文字幕在线| 麻豆久久精品国产亚洲av| 老熟妇乱子伦视频在线观看| 韩国av一区二区三区四区| 9191精品国产免费久久| 三级毛片av免费| 国产伦人伦偷精品视频| 久久精品影院6| 精品久久久久久久久亚洲 | 91九色精品人成在线观看| 午夜久久久久精精品| 女人被狂操c到高潮| or卡值多少钱| 亚洲激情在线av| 国产欧美日韩一区二区三| 国产私拍福利视频在线观看| 美女免费视频网站| 亚洲国产精品sss在线观看| 深夜a级毛片| 久久热精品热| 三级男女做爰猛烈吃奶摸视频| 国产精品永久免费网站| 亚洲精品影视一区二区三区av| 99热只有精品国产| 少妇被粗大猛烈的视频| 麻豆久久精品国产亚洲av| 一级黄色大片毛片| 欧美日本视频| 日韩欧美在线乱码| 直男gayav资源| 一进一出抽搐动态| 国产成人影院久久av| 国产精品自产拍在线观看55亚洲| avwww免费| 又粗又爽又猛毛片免费看| 黄色一级大片看看| 波多野结衣巨乳人妻| 中文字幕免费在线视频6| 亚洲成人久久爱视频| 午夜老司机福利剧场| 成人午夜高清在线视频| 日韩av在线大香蕉| 岛国在线免费视频观看| 国产高清有码在线观看视频| 亚洲黑人精品在线| 超碰av人人做人人爽久久| 国产国拍精品亚洲av在线观看| 国产高清视频在线观看网站| 五月玫瑰六月丁香| 亚洲美女视频黄频| av中文乱码字幕在线| ponron亚洲| 国产一级毛片七仙女欲春2| 国产探花极品一区二区| 国产又黄又爽又无遮挡在线| 亚洲人成伊人成综合网2020| 欧美乱妇无乱码| 免费搜索国产男女视频| 欧美日韩中文字幕国产精品一区二区三区| 亚洲精品色激情综合| 五月伊人婷婷丁香| 日韩精品中文字幕看吧| 亚洲人成网站高清观看| 国产高清三级在线| 久久国产精品人妻蜜桃| 天堂影院成人在线观看| 亚洲不卡免费看| 中文字幕人妻熟人妻熟丝袜美| 中文在线观看免费www的网站| 97超级碰碰碰精品色视频在线观看| 给我免费播放毛片高清在线观看| 日本 欧美在线| 在线观看美女被高潮喷水网站 | 九九热线精品视视频播放| 最新中文字幕久久久久| 久久精品夜夜夜夜夜久久蜜豆| 久久这里只有精品中国| 香蕉av资源在线| 亚洲熟妇中文字幕五十中出| 亚洲激情在线av| 欧美高清性xxxxhd video| 一个人免费在线观看电影| 哪里可以看免费的av片| 波多野结衣高清作品| 久久久成人免费电影| 久久精品国产自在天天线| 最新中文字幕久久久久| 国产欧美日韩一区二区三| 特大巨黑吊av在线直播| 国产亚洲精品久久久com| 亚洲国产精品成人综合色| 搡老妇女老女人老熟妇| 嫩草影院精品99| 亚洲无线在线观看| 国产一区二区激情短视频| 我的女老师完整版在线观看| 黄色女人牲交| www日本黄色视频网| 精品人妻1区二区| 久久热精品热| 悠悠久久av| 欧美一区二区精品小视频在线| 国产免费一级a男人的天堂| 午夜福利在线观看免费完整高清在 | 五月伊人婷婷丁香| 国产乱人视频| 日韩欧美国产一区二区入口| 在线a可以看的网站| 欧美绝顶高潮抽搐喷水| 国产伦在线观看视频一区| 亚洲无线观看免费| 国产激情偷乱视频一区二区| av黄色大香蕉| 国产在线精品亚洲第一网站| 赤兔流量卡办理| 搞女人的毛片| 变态另类成人亚洲欧美熟女| 久久国产精品影院| 网址你懂的国产日韩在线| 国产乱人伦免费视频| 国产精品98久久久久久宅男小说| 亚洲中文字幕一区二区三区有码在线看| 在线观看av片永久免费下载| av国产免费在线观看| 高清日韩中文字幕在线| 国产成年人精品一区二区| 观看美女的网站| 日韩亚洲欧美综合| 婷婷丁香在线五月| 成人美女网站在线观看视频| 国产精品99久久久久久久久| 亚洲成人免费电影在线观看| 国产爱豆传媒在线观看| 精品久久久久久久久亚洲 | 婷婷精品国产亚洲av在线| 日本五十路高清| 国产午夜精品久久久久久一区二区三区 | 国产亚洲精品av在线| 成人高潮视频无遮挡免费网站| 婷婷精品国产亚洲av| 波野结衣二区三区在线| 国产精品久久久久久久电影| 老熟妇仑乱视频hdxx| 一a级毛片在线观看| 国产欧美日韩一区二区三| 亚洲内射少妇av| 淫秽高清视频在线观看| 国产精品精品国产色婷婷| 18禁在线播放成人免费| 99在线视频只有这里精品首页| 久久九九热精品免费| 亚洲欧美日韩高清专用| 69人妻影院| www.www免费av| 精品一区二区三区视频在线| 麻豆av噜噜一区二区三区| 亚洲av免费高清在线观看| www.www免费av| 在线观看美女被高潮喷水网站 | 麻豆国产97在线/欧美| 欧美精品国产亚洲| 一级毛片久久久久久久久女| 18美女黄网站色大片免费观看| 99精品久久久久人妻精品| 亚洲第一欧美日韩一区二区三区| 国产大屁股一区二区在线视频| 麻豆一二三区av精品| 免费无遮挡裸体视频| 国产精品久久久久久亚洲av鲁大| 国产精品影院久久| 婷婷色综合大香蕉| 国产91精品成人一区二区三区| 99在线人妻在线中文字幕| 欧美一区二区亚洲| 最后的刺客免费高清国语| 国产单亲对白刺激| 真实男女啪啪啪动态图| 中文字幕高清在线视频| 精品福利观看| 九九在线视频观看精品| 国产精品综合久久久久久久免费| 麻豆久久精品国产亚洲av| 亚洲专区中文字幕在线| 精华霜和精华液先用哪个| 欧美黑人巨大hd| 国产亚洲av嫩草精品影院| 美女高潮的动态| 99久久精品一区二区三区| 永久网站在线| 久久欧美精品欧美久久欧美| 精品久久久久久,| 久久婷婷人人爽人人干人人爱| 男女床上黄色一级片免费看| 亚洲av电影在线进入| 欧美在线一区亚洲| 给我免费播放毛片高清在线观看| 国产麻豆成人av免费视频| 色综合欧美亚洲国产小说| 老女人水多毛片| 国内精品久久久久精免费| 色综合婷婷激情| 757午夜福利合集在线观看| 国产免费一级a男人的天堂| 国产精品久久久久久精品电影| or卡值多少钱| 麻豆国产av国片精品| 国产精品一区二区免费欧美| 小蜜桃在线观看免费完整版高清| 日韩中文字幕欧美一区二区| 午夜福利欧美成人| 久久久久久国产a免费观看| 在线观看美女被高潮喷水网站 | 性色avwww在线观看| 非洲黑人性xxxx精品又粗又长| 日本三级黄在线观看| 看片在线看免费视频| 日韩精品中文字幕看吧| 人人妻人人澡欧美一区二区| 高清日韩中文字幕在线| 日韩高清综合在线| 国产精品一区二区免费欧美| 夜夜看夜夜爽夜夜摸| 午夜影院日韩av| 变态另类丝袜制服| 国产精品久久视频播放| 国产精品嫩草影院av在线观看 | 亚洲片人在线观看| 欧美一区二区国产精品久久精品| 欧美日韩乱码在线| 欧美成人一区二区免费高清观看| 国产精品嫩草影院av在线观看 | 精品一区二区免费观看| 99在线人妻在线中文字幕| 制服丝袜大香蕉在线| 麻豆国产av国片精品| 国产大屁股一区二区在线视频| 亚洲中文日韩欧美视频| 永久网站在线| 亚洲综合色惰| 国产高清有码在线观看视频| 国产日本99.免费观看| 99热精品在线国产| 99国产精品一区二区三区| 成人av一区二区三区在线看| 最新中文字幕久久久久| 90打野战视频偷拍视频| 美女cb高潮喷水在线观看| 免费看日本二区| 波多野结衣巨乳人妻| 亚洲av二区三区四区| 亚洲精品一区av在线观看| 97超视频在线观看视频| 日本a在线网址| 精品熟女少妇八av免费久了| 国产精品久久电影中文字幕| 国产精品野战在线观看| 亚洲专区国产一区二区| 亚洲乱码一区二区免费版| АⅤ资源中文在线天堂| 99久久无色码亚洲精品果冻| x7x7x7水蜜桃| 欧美最黄视频在线播放免费| 日韩中文字幕欧美一区二区| 男女做爰动态图高潮gif福利片| 久久6这里有精品| 国内精品久久久久久久电影| 国产在线男女| 又紧又爽又黄一区二区| 亚洲片人在线观看| 亚洲七黄色美女视频| 欧美色欧美亚洲另类二区| 中文字幕久久专区| av天堂中文字幕网| 国产高清激情床上av| 天天躁日日操中文字幕| 99热这里只有精品一区| 久久精品国产亚洲av涩爱 | 午夜福利高清视频| 亚洲av电影在线进入| 99热6这里只有精品| 中文字幕av在线有码专区| 国产三级中文精品| 国产精品一区二区三区四区久久| 久久天躁狠狠躁夜夜2o2o| 精品日产1卡2卡| 757午夜福利合集在线观看| 日本与韩国留学比较| 久久久成人免费电影| 男人的好看免费观看在线视频| 国产精品亚洲av一区麻豆| 天堂av国产一区二区熟女人妻| 国产一区二区三区视频了| АⅤ资源中文在线天堂| 亚洲人成电影免费在线| 日韩国内少妇激情av| 草草在线视频免费看| 久久九九热精品免费| 亚洲精品亚洲一区二区| 深爱激情五月婷婷| xxxwww97欧美| 99久久99久久久精品蜜桃| 一级黄色大片毛片| 免费看a级黄色片| 少妇的逼好多水| 亚洲最大成人手机在线| 久久国产精品人妻蜜桃| 日本成人三级电影网站| 国内揄拍国产精品人妻在线| 我要搜黄色片| 99久久精品国产亚洲精品| 免费一级毛片在线播放高清视频| 我的老师免费观看完整版| 亚洲熟妇中文字幕五十中出| 久久久久九九精品影院| 国产av一区在线观看免费| av天堂中文字幕网| 高清日韩中文字幕在线| 亚洲五月婷婷丁香| 国产探花在线观看一区二区| 国产男靠女视频免费网站| 亚洲aⅴ乱码一区二区在线播放| 亚洲国产精品久久男人天堂| 九九在线视频观看精品| 国产91精品成人一区二区三区| 国产成人影院久久av| 久久国产精品人妻蜜桃| ponron亚洲| 美女xxoo啪啪120秒动态图 | 久久久久免费精品人妻一区二区| 免费看a级黄色片| 国产精品久久久久久人妻精品电影| 亚洲欧美精品综合久久99| 国产毛片a区久久久久| 欧美日韩黄片免| 亚洲国产欧美人成| 免费在线观看成人毛片| av专区在线播放| 国产乱人视频| 乱人视频在线观看| 久久草成人影院| 成人国产综合亚洲| 亚洲av美国av| 一级黄片播放器| 波多野结衣巨乳人妻| 成人国产一区最新在线观看| 国产三级黄色录像| 非洲黑人性xxxx精品又粗又长| 日日摸夜夜添夜夜添av毛片 | 国语自产精品视频在线第100页| 久久精品国产自在天天线| 日韩av在线大香蕉| 久久精品国产亚洲av天美| 99久久九九国产精品国产免费| 五月伊人婷婷丁香| 69av精品久久久久久| 免费黄网站久久成人精品 | 极品教师在线免费播放| 久久99热6这里只有精品| 亚洲一区二区三区不卡视频| 欧美日本亚洲视频在线播放| 在线观看美女被高潮喷水网站 | 在线国产一区二区在线| 国产野战对白在线观看| 91在线精品国自产拍蜜月| 99热这里只有精品一区| 亚洲人成网站在线播放欧美日韩| 亚洲,欧美精品.| 亚洲人成电影免费在线| 欧美高清成人免费视频www| 日本与韩国留学比较| 久久6这里有精品| 国内久久婷婷六月综合欲色啪| 在线观看免费视频日本深夜| 亚州av有码| av女优亚洲男人天堂| 国产精品人妻久久久久久| 久久亚洲精品不卡| 99riav亚洲国产免费| 亚洲在线自拍视频| 精品人妻偷拍中文字幕| 亚洲av一区综合| 欧洲精品卡2卡3卡4卡5卡区| 夜夜看夜夜爽夜夜摸| 亚洲av电影在线进入| 99热这里只有精品一区| 永久网站在线| av在线天堂中文字幕| 男人狂女人下面高潮的视频| 小说图片视频综合网站| 精品久久国产蜜桃| 老司机午夜福利在线观看视频| 网址你懂的国产日韩在线| 香蕉av资源在线| 禁无遮挡网站| 欧美乱色亚洲激情| 亚洲av.av天堂| 美女 人体艺术 gogo| 日本成人三级电影网站| 国产三级黄色录像| 免费在线观看亚洲国产| 免费看日本二区| 国产伦精品一区二区三区四那| 男人舔奶头视频| 中文字幕熟女人妻在线| 欧美丝袜亚洲另类 | 淫妇啪啪啪对白视频| av天堂在线播放| 亚洲精华国产精华精| 看免费av毛片| 精品久久久久久久久亚洲 | 丝袜美腿在线中文| 99久久成人亚洲精品观看| 国产精品人妻久久久久久| 亚洲自拍偷在线| 亚洲无线在线观看| 非洲黑人性xxxx精品又粗又长| 毛片女人毛片| 亚洲av中文字字幕乱码综合| 国产真实伦视频高清在线观看 | 我要看日韩黄色一级片| 免费黄网站久久成人精品 | 我要搜黄色片| 校园春色视频在线观看| 一区二区三区激情视频| 国产一区二区三区在线臀色熟女| 国产精品永久免费网站| 精品国产亚洲在线| 久久精品综合一区二区三区| 97超级碰碰碰精品色视频在线观看| 国产精品国产高清国产av| 亚洲av美国av| 免费看日本二区| 999久久久精品免费观看国产| 在线观看美女被高潮喷水网站 | 99国产精品一区二区三区| 美女高潮喷水抽搐中文字幕| 97超级碰碰碰精品色视频在线观看| av天堂中文字幕网| a级毛片a级免费在线| 亚洲男人的天堂狠狠| 亚洲乱码一区二区免费版| 日韩av在线大香蕉| 婷婷丁香在线五月| 动漫黄色视频在线观看| 黄色视频,在线免费观看| 亚洲男人的天堂狠狠| 成人国产一区最新在线观看| 久久午夜福利片| 韩国av一区二区三区四区| 色综合亚洲欧美另类图片| 无人区码免费观看不卡| 婷婷精品国产亚洲av| 国产一区二区三区在线臀色熟女| 99热这里只有精品一区| 午夜福利高清视频| 国产成人影院久久av| 久久精品国产亚洲av涩爱 | 一二三四社区在线视频社区8| 蜜桃久久精品国产亚洲av| 精华霜和精华液先用哪个| 女人被狂操c到高潮| 日韩欧美精品v在线| 国产美女午夜福利| 欧美最新免费一区二区三区 | 嫁个100分男人电影在线观看| 少妇熟女aⅴ在线视频| 国产国拍精品亚洲av在线观看| 99久久精品国产亚洲精品| 国内精品美女久久久久久| 黄色视频,在线免费观看| 午夜久久久久精精品| 深夜a级毛片| 午夜激情欧美在线| 亚洲第一区二区三区不卡| а√天堂www在线а√下载| 淫妇啪啪啪对白视频| 亚洲美女视频黄频| 老司机午夜十八禁免费视频| 国产午夜福利久久久久久| 亚洲aⅴ乱码一区二区在线播放| 亚洲成av人片在线播放无| 天堂√8在线中文| 最新在线观看一区二区三区| 亚洲 欧美 日韩 在线 免费| 国产黄色小视频在线观看| 十八禁国产超污无遮挡网站| av中文乱码字幕在线| 成人无遮挡网站| 国产熟女xx| 久久久久久久久久黄片| 亚洲精品456在线播放app | 男女那种视频在线观看| 村上凉子中文字幕在线| 久久久久九九精品影院| 久久久久久久久久成人| 日本精品一区二区三区蜜桃| 欧美成人免费av一区二区三区| 99久久久亚洲精品蜜臀av| 男女视频在线观看网站免费| 国产在线精品亚洲第一网站| 人人妻,人人澡人人爽秒播| 啪啪无遮挡十八禁网站| 麻豆一二三区av精品| 高清日韩中文字幕在线| 精品日产1卡2卡| 99国产极品粉嫩在线观看| 亚洲av免费高清在线观看| 亚洲无线观看免费| 久久人人爽人人爽人人片va | 亚洲在线观看片| 少妇被粗大猛烈的视频| 精品熟女少妇八av免费久了| 国产熟女xx| 国产av不卡久久| 中文字幕免费在线视频6| 好男人电影高清在线观看| 欧美成狂野欧美在线观看| 亚洲精品一卡2卡三卡4卡5卡| 舔av片在线| 国内精品久久久久精免费| 在线观看一区二区三区| 国内精品久久久久久久电影| 在线天堂最新版资源| 51午夜福利影视在线观看| 在线国产一区二区在线| 国产精品一区二区三区四区久久| 欧洲精品卡2卡3卡4卡5卡区| av欧美777| 麻豆av噜噜一区二区三区| 精品人妻偷拍中文字幕| 给我免费播放毛片高清在线观看| 欧美精品啪啪一区二区三区| 欧美日韩中文字幕国产精品一区二区三区| 99热这里只有是精品50| 色噜噜av男人的天堂激情| 三级毛片av免费| av天堂中文字幕网| 91在线精品国自产拍蜜月| 丁香六月欧美| 色吧在线观看| 亚洲不卡免费看| 搡老岳熟女国产| 免费在线观看成人毛片| 午夜福利高清视频| 色播亚洲综合网| 国产av麻豆久久久久久久| 人人妻人人澡欧美一区二区| 给我免费播放毛片高清在线观看| 国产毛片a区久久久久| 90打野战视频偷拍视频| 欧美一级a爱片免费观看看| 一进一出好大好爽视频| 亚洲第一电影网av| 男女做爰动态图高潮gif福利片| 亚洲一区高清亚洲精品|